ATED Therapeutics

Developing diagnostic blood tests and therapeutic drugs for Parkinson's disease and other central nervous system disorders.

Health Tech & Life Sciences

Active

Pre-Funding Tel Aviv, Israel Founded 2022

Last updated 2026-08-23

Raised $670k Seed round, Oct 2024

Total raised

$670K

Stage

Pre-Funding

Founded

2022

Headcount

Tel Aviv, Israel

Sector

Health Tech & Life Sciences

Website ↗LinkedIn ↗Registrar ID: 516586864 (ATED Therapeutics Ltd.)

About

ATED Diagnostics, Ltd is dedicated to developing cutting-edge diagnostics for neurodegenerative diseases and then bringing them to the patient. They have forged strategic partnerships with prominent scientists at institutions like Hebrew University to transform neuroscience research into commercially viable medical advancements. Their initial work in neurodevelopmental disorders offered key insights, leading them to pursue Parkinson's Disease. Their focus is to bring the work of Drs. Hermona Soreq and Daphne Atlas at Hebrew University to the clinic, and improving the diagnosis of Parkinson’s Disease with a planned clinical trial for their tRF test. ATED Therapeutics Ltd. is an Israeli and U.S. based company dedicated to development of a diagnostic blood test as well as therapeutic drugs to treat Parkinson’s Disease.

Funding history · 1 round · $670K total

1 event/round · $670K Total Funding: $670K in Private Equity

Oct 2024

Seed $670K tracxn.com

Headcount over time

2 employees (2026-09) · 1 point

Offices

Tel Aviv, Israel · HQ / main office

Q&A

What is ATED Therapeutics' primary focus?: ATED Therapeutics develops diagnostics and therapeutics for Parkinson’s disease and other central nervous system diseases.
What is ATED Therapeutics' lead product?: ATED Therapeutics' lead product is an investigational transfer RNA fragment blood test designed to detect Parkinson’s earlier, monitor disease progression, and quantify response to deep brain stimulation.
What other products is ATED Therapeutics developing?: The company is also developing two disease-modifying Parkinson’s drug candidates.
When was ATED Therapeutics founded?: ATED Therapeutics was founded in March 2022.
How many employees does ATED Therapeutics have?: ATED Therapeutics has 1-10 employees.
What is ATED Therapeutics' current funding stage?: ATED Therapeutics is currently in the Pre-Funding stage.
Where is ATED Therapeutics headquartered?: ATED Therapeutics is headquartered in Tel Aviv-Yafo, Israel.
What are the primary sectors ATED Therapeutics operates in?: ATED Therapeutics operates in the Health Tech & Life Sciences, Medical Devices, and Diagnostics Devices sectors.

Team · 10

Jeff R. Swarz

Founder · Chief Executive Officer

Joseph Chiarelli

Founder · Chief Financial Officer

Daniel Jorgensen

Chief Medical Officer

Lawrence Florin

Regulatory Strategist

Hermona Soreq